Dr. Rosa Maria Razaboni, FACS, MD

Dr. Razaboni practices at Northern Westchester Hospital in Mount Kisco, New York, part of Northwell Health.

Dr. Razaboni's NPI, 1225048853, was assigned on August 8, 2006. Dr. Razaboni holds New York license 163063.

Dr. Razaboni's primary practice is Northern Westchester Hospital, at 400 East Main Street, Mount Kisco, NY 10549 in Westchester County. The practice phone is (914) 666-1200.

Dr. Razaboni's primary practice is Northern Westchester Hospital in Mount Kisco, New York, part of Northwell Health. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Razaboni practices. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Razaboni's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Razaboni is licensed in New York.

CMS data shows 30 Medicare services from Dr. Razaboni across 2 procedure codes in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $5,251 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Razaboni in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high cholesterol, and 66% have cancer. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Razaboni's median patient age at 60, with 94% women.

In 2024, Dr. Razaboni wrote 19 Medicare Part D claims. 95% of them were for generic drugs. They cover 2 drugs, with $199 in total drug cost. In 2022, CMS named 32 claims across 2 drugs.

Dr. Razaboni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 39 procedures of mastectomy by Dr. Razaboni, more than 91% of the clinicians it reports for that procedure.

CMS Open Payments shows 5 general payments to Dr. Razaboni from 2 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Pacira Pharmaceuticals Incorporated paid the most, $94.